Clinical trial · Interventional
Use of tDCS Stimulation in Neurological and Gynaecological Conditions
NCT06891690CI-TRIAL-00087602tDCSrecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260926-000001
Summary
Brief summary (as posted)
The aim of the study is to test the effect of tDCS stimulation on upper and lower limb function in neurological patients and to reduce pain in gynaecological patients. And the impact of tDCS stimulation on patients' quality of life. Standardised questionnaires will be used for pre- and post-stimulation evaluation.
Conditions
Conditions (7)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Dyspareunia | — | UNRESOLVED | — |
| Endometriosis | — | UNRESOLVED | — |
| Nerve Root Disorder | — | UNRESOLVED | — |
| Painful Menstruation | — | UNRESOLVED | — |
| Polycystic Ovary | — | UNRESOLVED | — |
| Spinal Cord Diseases | — | UNRESOLVED | — |
| Stroke | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| tDSC stimulation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- tDCS stimulation
- description
- The study group will have tDCS stimulation.
- interventionNames
- Other: tDSC stimulation
Primary outcomes (21)
- measure
- body height using Tanita BC-418 MA device
- timeFrame
- through study completion, an average of 1 year
- description
- height will be measured in centimeters
- measure
- biomechanical and viscoelastic properties of the skin using MyotonPRO
- timeFrame
- through study completion, an average of 1 year
- description
- The tissue voltage will be measured in Hertz (Hz)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Neurological patients Inclusion Criteria: * impairment of upper and lower limb function. Exclusion Criteria: * no written consent to participate in the study. Gynaecological patients Inclusion Criteria: * women with selected gynaecological conditions (endometriosis, painful menstruation, dyspareunia, polycystic ovary syndrome) with no treatment other than tDCS stimulation. Exclusion Criteria: * no written consent to participate in the study.
References
Publications (0)
Data not yet available
No reference posted for this study.